Argatroban Injection Shortage
Last Updated: March 21, 2024
Status: Current
Products Affected - Description
-
- Argatroban intravenous injection, Fresenius Kabi, 100 mg/mL, 2.5 mL vial, 1 count, NDC 63323-0526-03 - discontinued
Reason for the Shortage
-
- Eugia has argatroban available.
- Fresenius Kabi has argatroban available. The 100 mg/mL 2.5 mL vials have been discontinued.
- Hikma has argatroban available.
- Viatris did not provide a reason for the shortage.
- Novartis discontinued argatroban.
- Par has argatroban available.
- Pfizer has argatroban available.
- Sagent has argatroban available.
- Sandoz discontinued argatroban 1 mg/mL 50 mL vials in April 2019. Sandoz discontinued argatroban 1 mg/mL 125 mL vials in April 2020.
- Teva is not marketing argatroban.
Available Products
-
- Argatroban intravenous injection, Eugia US, 1 mg/mL, 50 mL vial, 1 count, NDC 55150-0241-01
- Argatroban intravenous injection, Eugia US, 1 mg/mL, 50 mL vial, 10 count, NDC 55150-0241-10
- Argatroban intravenous injection, Fresenius Kabi, 1 mg/mL, 50 mL vial, 10 count, NDC 65219-0429-50
- Argatroban intravenous injection, Hikma, 1 mg/mL, 50 mL vial, 1 count, NDC 00143-9559-01
- Argatroban intravenous injection, Hikma, 100 mg/mL, 2.5 mL vial, 1 count, NDC 00143-9674-01
- Argatroban intravenous injection, Mylan Institutional (Viatris), 100 mg/mL, 2.5 mL vial, 1 count, NDC 67457-0212-02
- Argatroban intravenous injection, Par Pharmaceuticals, 100 mg/mL, 2.5 mL vial, 1 count, NDC 42023-0182-01
- Argatroban intravenous injection, Pfizer, 100 mg/mL, 2.5 mL vial, 1 count, NDC 00409-1140-01
- Argatroban intravenous injection, Sagent, 1 mg/mL, 50 mL vial, 1 count, NDC 25021-0414-50
Estimated Resupply Dates
-
- All marketed presentations are available.
Updated
Updated March 21, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 20, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.